Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa.
S Afr Med J. 2021 Mar 31;111(4):355-360. doi: 10.7196/SAMJ.2021.v111i4.15171.
The quality of international normalised ratio (INR) control determines the effectiveness and safety of warfarin therapy. Data on INR control in non-metropolitan settings of South Africa (SA) are sparse.
To examine the time in therapeutic range (TTR) and its potential predictors in a sample of Garden Route District Municipality primary healthcare clinics (PHCs).
INR records from eight PHCs were reviewed. The TTR and percentage of patients with a TTR >65% were determined. A host of variables were analysed for association with TTR.
The median (interquartile range (IQR)) age of the cohort (N=191) was 56 (44 - 69) years. The median (IQR) TTR was 37.2% (20.2 - 58.8); only 17.8% of patients had a TTR ≥65%. Compared with patients aged >50 years, those aged <50 had worse INR control (median (IQR) TTR 26.6% (16.1 - 53.0) v. 43.5% (23.5 - 60.1); p=0.01). Patients hospitalised for any reason during the study period had worse INR control than patients not hospitalised (median (IQR) TTR 26.2% (16.2 - 50.2) v. 42.9% (23.5 - 62.0); p=0.02). On multivariable regression analysis, participants on warfarin for atrial fibrillation/flutter had better INR control than those with other indications for warfarin (odds ratio 2.21; 95% confidence interval 1.02 - 4.77; p=0.04), but the control was still very poor.
INR control, as determined by TTR and proportion of TTR ≥65%, in these non-metropolitan clinics was poor. Age and hospitalisation as a marker of illness predicted poor control. There was a difference in control between groups, depending on the indication for warfarin. Evidence-based measures to improve the quality of INR control in patients on warfarin therapy need to be instituted as a matter of urgency.
国际标准化比值(INR)控制的质量决定了华法林治疗的有效性和安全性。南非(SA)非大都市地区 INR 控制的数据很少。
在花园路线区直辖市的一个初级保健诊所(PHC)样本中,检查治疗范围内的时间(TTR)及其潜在预测因素。
审查了 8 个 PHC 的 INR 记录。确定 TTR 和 TTR > 65%的患者比例。分析了大量变量与 TTR 的关联。
队列(N=191)的中位(四分位距(IQR))年龄为 56(44-69)岁。中位(IQR)TTR 为 37.2%(20.2-58.8);只有 17.8%的患者 TTR ≥65%。与 > 50 岁的患者相比,< 50 岁的患者 INR 控制更差(中位数(IQR)TTR 26.6%(16.1-53.0)v. 43.5%(23.5-60.1);p=0.01)。研究期间因任何原因住院的患者的 INR 控制比未住院的患者差(中位数(IQR)TTR 26.2%(16.2-50.2)v. 42.9%(23.5-62.0);p=0.02)。多元回归分析显示,因心房颤动/扑动而服用华法林的患者 INR 控制优于因其他原因服用华法林的患者(比值比 2.21;95%置信区间 1.02-4.77;p=0.04),但控制仍然很差。
这些非大都市诊所的 INR 控制,由 TTR 和 TTR > 65%的比例来确定,很差。年龄和住院作为疾病的标志物预测控制不良。根据华法林的适应症,控制存在差异。需要紧急制定改善华法林治疗患者 INR 控制质量的循证措施。